Tom Mueller, Chief Commercial Officer, ACM Global Laboratories
NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
In our rapidly evolving clinical research industry, there’s never been a more important time to ensure you’re getting the most out of your central laboratory services. This is especially true in the face of the challenges brought about by the COVID-19 pandemic. While the landscape of clinical research continues to evolve and shift, the criticality of choosing a trusted and qualified central lab partner is paramount for future clinical trial success.
Personalized Touch with a Global Reach
Guiding your study through its entire life cycle, our expert scientists, projects managers, and logistics coordinators partner with clients to deliver seamless study management and results, supporting regulatory submissions, preclinical studies, and clinical trials in more than 65 countries, every day.
Instrumental in our approach, is our focus on providing clients with the expertise and actionable clinical insights that they need to bring their products to market. From bespoke bioanalytical services and a custom approach to kit creation, to the highest-attention to sample and data management and oversight; we are committed to delivering the flexibility and transparency that you and the participating patients expect and deserve throughout the clinical trial process.
Our comprehensive laboratory services include: pharmacokinetic (PK) and pharmacodynamic (PD) biomarker analysis, smoking and nicotine research, bioanalytical services, molecular testing capabilities with a current emphasis on COVID-19 testing, pathology expertise, routine safety testing, toxicology, flow cytometry, and viral testing. Committed to delivering accurate, reproducible results for trials on a global scale, we are adept at supporting the full range of therapeutic studies for research and development programs worldwide.
On the Frontlines of Bioanalytical Capabilities
Formerly ABS Laboratories, ACM’s bioanalytical division, ACM Bioanalytical Services, provides the critical insights you need to advance your drug development program. Our Technical Director Mira Doig, Ph.D., is a seasoned expert dedicated to providing the best services the industry has to offer. With more than 30 years of experience performing regulated bioanalysis of drugs, metabolites, and biomarkers using GC-MS & LC-MS/MS, she and her team have supported multiple drug development programs from discovery to MAA/NDA submission.
Our bioanalytical experts support studies in a broad range of therapeutic areas including nicotine and cannabinoids and offer complex assay method development and validation. We provide tailored bioanalytical services to ensure every aspect of your trial will receive the same personalized touch by committed employees.
We’re Ready and Able to Tackle Any Clinical Study
Experience means something, and at ACM, we’ve amassed more than 40 years of laboratory testing, employ 20-plus board-certified pathologists, and have managed more than 2,800 clinical studies across the globe — thanks to our global team of dedicated employees.
Our experience and our exceptional team have helped ensure that over the last unprecedented year, ACM has remained nimble, ready and able to tackle any study. We’ve launched complex, global trials on time and have ensured that study sites get the materials they need, when they need them. We know that the global market is demanding more, demanding faster and demanding better, actionable results, and we’re here to deliver just that. And to do so while staying focused on our mission — supporting our clients and delivering the insights they need to promote health, healing and hope to patients around the world.(PV)
ACM Global Laboratories, an affiliate of Rochester Regional Health, is one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology, and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 30 million laboratory tests each year — spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more.
For more information, visit ACMGlobalLab.com.